Biotrue
Device Ophthalmology
General payments
$4,382,683
Research payments
$62,266
Through program year 2025, $4,382,683 in general payments and $62,266 in research payments were reported against Biotrue (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $69,806 | 1,165 |
| 2024 | General | $92,855 | 1,058 |
| 2023 | General | $164,160 | 1,184 |
| 2022 | General | $299,428 | 1,039 |
| 2021 | General | $243,960 | 703 |
| 2020 | General | $751,652 | 1,727 |
| 2020 | Research | $62,266 | 15 |
| 2019 | General | $2,760,822 | 11,973 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
18,849 general · 15 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.